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Early events leading to HIV infection across the mucosa
likely involve HIV capture by a wide variety of molecules
on the surface of epithelial cells and leukocytes followed
by infection of permissive target cells within the tissues. In
studying this biology, we are focusing on the contribution
of dendritic cells (DCs) and T cells to these events and
exploring effective ways to block these complex events in
vitro and in vivo. Earlier work confirmed that there are at
least two phases of DC-driven transmission of virus to T
cells – one involves virus captured by (but not infecting)
DCs that is handed directly over to the T cells and the
other involves DC infection and the transmission of
newly synthesized viruses. Virus captured by DCs is trans-
mitted to CD4 T cells moving rapidly across the synapse
naturally created between DCs and T cells. Inclusion of
the fusion inhibitor T1249 reduces the amount of virus
movement to the T cells, while increasing the amount of
virus accumulating in the DCs. The immunologic and
virologic consequences of this are under investigation.
These data highlight how only blocking certain pathways
of virus-DC interactions are suboptimal in preventing DC-
driven HIV spread. As a result, additional studies are being
performed to test the ability of more broad-acting carra-
geenan-based formulations for their ability to impede the
complex virus-cell interplay needed to facilitate transmis-
sion. Carrageenan-based microbicides are promising due
to their wide rage of activity against HIV/SIV and other
sexually transmitted pathogens. Carrageenans impair
virus capture by DCs in vitro and block infection of per-
missive DC-T cell mixtures. Recent in vivo data revealed
that macaques were protected against vaginal SHIV chal-
lenge by carrageenan-based microbicides. These data are
encouraging for future application of carrageenan-based
formulations in preventing HIV spread.
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